首页 | 本学科首页   官方微博 | 高级检索  
检索        


Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists
Authors:Xinli Duan  Xin Zhang  Binglin Xu  Fang Wang  Ming Lei
Institution:1. State Key Laboratory of Chemical Resource Engineering, Institute of Materia Medica, College of Science, Beijing University of Chemical Technology, Beijing, China;2. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
Abstract:Dopamine D3 receptor (D3R) is considered as a potential target for the treatment of nervous system disorders, such as Parkinson's disease. Current research interests primarily focus on the discovery and design of potent D3 agonists. In this work, we selected 40 D3R agonists as the research system. Comparative molecular field analysis (CoMFA) of three‐dimensional quantitative structure–activity relationship (3D‐QSAR), structure–selectivity relationship (3D‐QSSR), and molecular docking was performed on D3 receptor agonists to obtain the details at atomic level. The results indicated that both the CoMFA model (r2 = 0.982, q2 = 0.503, urn:x-wiley:17470277:media:cbdd12743:cbdd12743-math-0001 = 0.893, SEE = 0.057, F = 166.308) for structure–activity and (r2 = 0.876, q2 = 0.436, urn:x-wiley:17470277:media:cbdd12743:cbdd12743-math-0002 = 0.828, F = 52.645) for structure–selectivity have good predictive capabilities. Furthermore, docking studies on three compounds binding to D3 receptor were performed to analyze the binding modes and interactions. The results elucidate that agonists formed hydrogen bond and hydrophobic interactions with key residues. Finally, we designed six molecules under the guidance of 3D‐QSAR/QSSR models. The activity and selectivity of designed molecules have been improved, and ADMET properties demonstrate they have low probability of hepatotoxicity (<0.5). These results from 3D‐QSAR/QSSR and docking studies have great significance for designing novel dopamine D3 selective agonists in the future.
Keywords:3D‐QSAR  3D‐QSSR  agonist  dopamine D3 receptor  molecular docking
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号